Palomino Laboratories (PALX) Operating Expenses (2023 - 2025)

Palomino Laboratories (PALX) has 3 years of Operating Expenses data on file, last reported at -$1.9 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses fell 1499.08% year-over-year to -$1.9 million; the trailing twelve-month figure through Dec 2025 stood at -$271897.0 (down 222.32% YoY), and the FY2025 full-year result was $30000.0, down 78.58% from the prior year.
• Operating Expenses retreated to -$1.9 million in Q4 2025, from $1.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.6 million in Q3 2025 to a low of -$1.9 million in Q4 2025.
• A 3-year average of $2583.1 and a median of $34061.0 in 2023 frame the typical range for Operating Expenses.
• Peak annual rise in Operating Expenses reached 129958.51% in 2025, while the deepest fall reached 1499.08% in 2025.
• Tracing PALX's Operating Expenses over 3 years: stood at $32574.0 in 2023, then soared by 323.53% to $137962.0 in 2024, then tumbled by 1499.08% to -$1.9 million in 2025.
• Business Quant data shows PALX's Operating Expenses at -$1.9 million in Q4 2025, $1.6 million in Q3 2025, and $35548.0 in Q2 2025.